Vaxart (VXRT) Misses Q2 EPS by 3c

Vaxart (NASDAQ: VXRT) reported Q2 EPS of ($0.06), $0.03 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $27.19 million versus the consensus estimate of $50.5 million.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• Robinhood Ventures Fund II opens at $22.50, IPO at $25
• Cantor Fitzgerald Reiterates Overweight Rating on Global Net Lease (GNL)
• Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions